UPDATE: BAD & UGLY, UPS & DOWN

Last Friday, the Canadian Broadcast Corporation (CBC) reported that recently imported doses of the Johnson & Johnson vaccine were blocked from use after confirmation they came from the same U.S. manufacturing plant “mired in quality-control problems.” 

Last month, it was revealed that 15 million doses of the vaccine had been contaminated at the Emergent BioSolutions plant in Baltimore.

The CBC report noted: “Health Canada’s pause on the J&J shot is a setback for the country’s efforts to continue ramping up vaccinations amid a raging third wave of the pandemic.” Health Canada had originally given the stamp of approval to the vaccine back in March and then “had updated its labelling on Monday to acknowledge the risk of rare but serious blood clots.”

Yesterday, Denmark stopped its J&J COVID-19 vaccine rollout. The statement read: 

“The Danish Health Authority has concluded that the benefits of using the COVID-19 vaccine from Johnson & Johnson do not outweigh the risk of causing the possible adverse effect, VITT, in those who receive the vaccine. Therefore, the Danish Health Authority will continue the Danish mass vaccination programme against COVID-19 without the COVID-19 vaccine from Johnson & Johnson.”

TRENDPOST: In the world of overt hypocrisy, if anyone in the medical field outside the government were to question the efficacy and dangers of the J&J jab, they would be censored by the mainstream and social media and denounced as “conspiracy theorists.”

More Trouble in AstraZeneca Paradise

The Wall Street Journal reported last Friday that executives of the large British/Swedish pharmaceutical company AstraZeneca, which produces one of the COVID vaccines on the market, “have struggled to pull together the full data necessary to apply for U.S. approval… further delaying its efforts to secure the Food and Drug Administration’s go-ahead.”

The company announced it will apply for Emergency Use Authorization by the middle of April, however, it concedes it will take at least until mid-May to complete the necessary documents for FDA confirmation. 

Important to note is that on 9 April, Time magazine reported:

“While the AstraZeneca vaccine is not yet authorized in the U.S., about 25 million people around the world have received it, and in March, after dozens of reports of blood clots occurring mainly in younger people who received the shot, and about 18 deaths, many countries temporarily halted vaccination.”

Moderna & The Three-Billion-Dose Jackpot

The Wall Street Journal reported last Friday that Moderna Inc, makers of another popular COVID vaccine in use, plans to spend billions of dollars to triple its dose output in 2022, citing increased global demand. 

This follows last week’s report that Moderna reached an agreement with Israel, which includes options for variant vaccines. The company’s chief executive, Stephane Bance, said, “We really believe that the virus is going to keep evolving fast with new mutations and that variant boosters are a must for us to stop this pandemic.”

Note: As previously reported in the Trends Journal in our 20 April article, “U.S. GOV’T PLEDGE: $1.7B TO FIGHT COVID VARIANTS,” the “variant” scare is unsubstantiated by data:

Ignoring the solid scientific data, the Biden administration is allocating $1.7 billion of the $1.9 billion American Rescue Plan to “tackle” so-called dangerous variants. This even though in the U.K., only 9 percent of tests conducted found variants.


Support the Trends Journal with these great products


2 Comments
  1. harlow53 7 months ago

    This is so important I am splitting it into two messages. This is part one:
    05/10/21

    BIG PHARMA › NEWS
    EU Regulators Call on Pfizer, Moderna, AstraZeneca for More Data on Heart Inflammation, Guillain–Barré Syndrome
    The European Medicines Agency also wants Pfizer and Johnson & Johnson to update warnings and lists of side effects relating to face swelling (Pfizer) and blood clots (J&J).

    By
    Megan Redshaw

    2

    Link copied
    EMA recommends updates to labels, lists of side effects.
    The Defender is experiencing censorship on many social channels. Be sure to stay in touch with the news that matters by subscribing to our top news of the day. It’s free.

    EU regulators Friday called on Pfizer and Moderna to provide additional data related to the companies’ COVID vaccines and a potential link to heart inflammation, after the agency completed a safety review of all four COVID vaccines authorized for emergency use in the EU.

    The European Medicines Agency’s safety committee, (PRAC), also asked AstraZeneca for data related to reports of Guillain–Barré syndrome in people who received the AstraZeneca vaccine, and they recommended Pfizer and Johnson & Johnson (J&J) update their labels with side effect warnings.

    In a report issued May 7, PRAC disclosed its members were aware of cases of myocarditis and pericarditis following Pfizer vaccination. Regulators said they didn’t see an indication the vaccine caused these cases, but as a prevention, PRAC requested Pfizer provide further data, including an analysis of events according to age and gender in its next pandemic summary safety report and will consider if any other regulatory action is needed.

    Because Moderna and Pfizer use the same mRNA technology for their vaccines, the committee asked Moderna to monitor for similar cases of heart inflammation.

    Myocarditis, or inflammation of the heart muscle, can lead to cardiac arrhythmia and death. Pericarditis is inflammation of the membrane around the heart.

    A search in the CDC’s Vaccine Adverse Events Reporting System (VAERS) revealed 213 cases of pericarditis and myocarditis reported in the U.S following COVID vaccination. Of the 213 cases reported, 105 cases were attributed to Pfizer, 93 cases to Moderna and 15 cases to Johnson & Johnson’s (J&J) COVID vaccine.

    On April 27, Reuters reported the U.S. Department of Defense was investigating 14 cases of heart inflammation among people who were vaccinated through the military’s health services.

    CHD and The Defender Now in 5 Languages – Watch Now
    Of the 14 cases, one patient developed myocarditis after their first dose of vaccine. The remaining 13 patients developed myocarditis after their second vaccine doses. Eleven received the Moderna vaccine and three received Pfizer.

    Israel’s Health Ministry is also examining cases of heart inflammation in people who received Pfizer’s COVID vaccine. As The Defender reported April 26, a preliminary report by the committee tasked with monitoring vaccine side effects in Israel identified 62 cases of myocarditis, including two deaths, after recent vaccination with Pfizer. Fifty-five of the cases occurred in men — most between ages 18 and 30.

    In the case of AstraZeneca, PRAC said it is examining reports of Guillain–Barré syndrome and asked for more detailed data and an analysis of all reported Guillain–Barré syndrome cases.

    Guillain–Barré syndrome is a rare immune disorder in which the body’s immune system attacks the nerves resulting in paralysis. It had been previously identified by regulators as a potential adverse side effect that required monitoring following AstraZeneca’s shot

  2. harlow53 7 months ago

    This message is the 2nd part of the above message:

    EMA recommends updates to labels, lists of side effects

    The EMA’s May 7 report also included the recommendation that Pfizer add a new side effect to its product information for people with dermal fillers — soft, gel-like substances injected under the skin.

    After reviewing all available evidence, including cases reported to the European database for suspected side effects and data from scientific literature, PRAC said there is at least a “reasonable possibility of a causal association between the vaccine and the reported cases of facial swelling in people with a history of injections with dermal fillers.”

    The safety committee also said it would update its warning for J&J’s COVID vaccine after EU regulators in April identified a link between the shot and blood clots.

    Though PRAC said the benefits of the vaccine outweigh the risks, the label will now include advice that patients diagnosed with thrombocytopenia within three weeks of vaccination be actively investigated for signs of thrombosis and that patients who present with thromboembolism within three weeks be evaluated for thrombocytopenia.

    Thrombosis with thrombocytopenia syndrome will also be added as an “important identified risk” in the risk management plan for J&J’s vaccine. The committee asked the company to provide a plan to further study the possible underlying mechanisms for these events.

    Additionally, PRAC looked at clotting risks with Pfizer and Moderna vaccines. Though several cases of low blood platelets and blood clots were identified, the committee concluded that for the moment there does not seem to be any evidence of a safety signal for the mRNA shots.

    Utilizing a search criteria that included reports of blood clots associated with blood clotting disorders, VAERS yielded a total of 2,808 reports in the U.S for all three vaccines from Dec. 14, 2020, through April 30. Of the 2,808 cases reported, there were 1,043 reports of blood clotting disorders attributed to Pfizer.

    As The Defender reported Monday, a Utah teen remains hospitalized with three blood clots in and near his brain that developed after he received the first dose of Pfizer’s COVID vaccine.

    On May 7, Pfizer became the first COVID vaccine producer to request full approval by the U.S Food and Drug Administration for ages 16 and up. Pfizer requested priority review, which asks the FDA to take action within six months, compared to 10 months designated under standard review.

    The FDA is expected to amend Pfizer’s Emergency Use Authorization (EUA) this week to authorize use of the vaccine in adolescents aged 12 to 15. The company announced plans to further expand EUA for its vaccine for children ages 2 to 11 in September.

    If approved, Pfizer will be the first experimental vaccine to receive full approval by the FDA.

    It is time to activate the Worldwide Class Action Lawsuit for a Crimes Against Humanity Trial at The Hague for violation of the Nuremberg Code of experimental medical conduct and haul all the individuals, nations, states, Bill and Melinda Gates Foundations, GAVI, UN, WHO, WEF, W Buffett, BIG PHARMA, BIG TECH, MEDIA, CCP, PENTAGON, A Fauci, and anyone who participated in the mRNA Gain of Function experimental gene therapy research that created the Bioweapon COVID-19 Coronavirus. The Nuremberg Trial must be conducted to bring charges against thosein violation of the human’s individual right of informed consent that was by-passed by the establishments worldwide!!!

Leave a reply

©2021 The Trends Journal

Log in with your credentials

Forgot your details?